Pluri Inc. (PLUR) vs Tvardi Therapeutics, Inc. (TVRD)
A side-by-side comparison of Pluri Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PLUR
Pluri Inc.
$0.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVRD
Tvardi Therapeutics, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PLUR vs TVRD
growth of $100 · dividends reinvested · last 1yPLUR -71.4% (-71.4%/yr)TVRD -76.7% (-76.7%/yr)PLUR compounded faster over this window
PLUR TVRD
PLUR vs TVRD: by the numbers
- •PLUR is the larger company ($11M vs $10M market cap).
- •Both run net losses; TVRD's is the smaller (0.00% vs -2406.00% net margin).
Metrics side by side
Valuation
| Metric | PLUR | TVRD |
|---|---|---|
| P/S ratio | 10.51 | N/A |
| P/B ratio | N/A | 1.21 |
Profitability
| Metric | PLUR | TVRD |
|---|---|---|
| Gross margin | 44.59% | 0.00% |
| Operating margin | -2455.91% | 0.00% |
| Net margin | -2406.00% | 0.00% |
| ROE | N/A | -310.94% |
| ROIC | -127.37% | -323.71% |
Growth (annualized)
| Metric | PLUR | TVRD |
|---|---|---|
| Total return CAGR (5Y) | -44.78% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.